TheraCann Launches ETCH Biotrace™ Technology
PANAMA PACIFICO, Panama, Aug. 1, 2018
PANAMA PACIFICO, Panama, Aug. 1, 2018/PRNewswire/ -- TheraCann International Benchmark Corporation ("TheraCann"), a leading full service international cannabis business and "seed to sale" technology firm in conjunction with Applied DNA Sciences, Inc., (NASDAQ: APDN), the leader in molecular technologies for supply chain transparency, announced the launch of their breakthrough ETCH biotrace™ technology. The molecular "tag and trace" system will be included with TheraCann's BenchmarkSOLUTION of licensing, project management, security, cultivation, and analysis services.
TheraCann's ETCH biotrace™ platform is poised to further refine and transform the cannabis regulatory environment by adding capabilities that allow for the forensic tracking of cannabis and cannabis derivatives across the supply chain. Whether it is introduced at the cultivator, processor or manufacturer level, ETCH biotrace links a unique molecular tag to the cannabis plant that will survive conversion or extraction. Using a simple hand-held device, molecular testing can be performed at any point in the supply chain to verify compliance. The technology also has the potential to drive a sea change in the way brands catalog, manage and track their intellectual property.
The rapid global adoption of cannabis legislation has accelerated the need to secure and truly validate cannabis supply chains from seed-to- sale. Current systems, many of which rely on RFID or bar code technologies, are capable of accurately tacking cannabis supply chains through the cultivation stage but cannot forensically track cannabis and/or cannabis derivative products back to a specific source once the physical tags and packaging are removed.
"TheraCann is excited to fully introduce this breakthrough molecular tag and trace technology. Global regulatory bodies and cannabis brands have been limited by their reliance on traditional RFID and stickering systems," said Jason Warnock, Chief Executive Officer of TheraCann International Benchmark Corporation. "The combination of TheraCann's integration software and EPCIS Standardized blockchain systems through Multichain Ventures (dba the Tokes Platform), with Applied DNA Science's proven CertainT® platform creates a safe and secure way to manage the legal supply chain."
"The molecular tags used in the ETCH biotrace system is considered GRAS (Generally Recognized as Safe), they are non-GMO," said Dr. James Hayward, President and CEO of Applied DNA Sciences. "The typical daily diet includes about 100 parts DNA per million parts of food. Orally ingested DNA is hydrolyzed by the pH in the stomach. Our molecular tags are very small; too small to function as genes. Typical tagging levels of use are in parts per billion, levels too small to have any impact on form or function, or the biological properties of cannabis."
The ETCH biotrace patented technology provides true traceability including the ability to track products from cultivation, extraction and derivative processing into edibles or other forms that will provide a clear method to eliminate black and grey market products from entering the regulated marketplace worldwide.
TheraCann's ETCH biotrace technology is currently in beta testing with multiple cultivators and will be available to clients, regulatory bodies and cannabis brands in legal municipalities throughout the world.
More information about ETCH biotrace is available at www.etchbiotrace.com
About TheraCann International Benchmark Corporation
Founded in 2004, TheraCann International Benchmark Corporation offers a one-stop, full-service solution for the International cannabis marketplace. TheraCann provides business, technology and industry experts who apply advanced technology and help clients design, build and run their cannabis businesses. Integrating nearly 3.5 million square feet of cannabis operations and the successful launch of groundbreaking Enterprise Resource Planning (ERP) software, Aeroponic cultivation systems and patented genetic tracking and diversion prevention systems, TheraCann provides cannabis-related businesses with solutions to fit their regulatory requirements.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.
Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-molecular based "CertainT®" platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products. SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
Visit www.adnas.com for more information.
SOURCE TheraCann International Benchmark Corporation